Diabetes, Vol 44, Issue 9 1121-1125, Copyright © 1995 by American Diabetes Association

ARTICLES

Effect of obesity on insulin resistance in normal subjects and patients with NIDDM

B Ludvik, JJ Nolan, J Baloga, D Sacks and J Olefsky
Department of Medicine, University of California, San Diego, USA.

Insulin resistance (IR) is a characteristic feature of non-insulin-dependent diabetes mellitus (NIDDM) as well as obesity, and a majority of NIDDM patients are obese. To assess the effect of obesity independent of NIDDM on IR, we studied the relationship between IR and obesity in 65 normal and 58 NIDDM subjects; we used body mass index (BMI) as a measure of obesity and glucose infusion rate (GINF) during a euglycemic hyperinsulinemic (120 mU.m-2.min-1) glucose clamp as a measure of IR. In lean normal subjects, GINF was 57.7 +/- 2.2 mumol.kg-1.min-1 (10.4 +/- 0.4 mg.kg-1.min-1) and the lean NIDDM subjects were markedly insulin-resistant, with a GINF of 34.4 +/- 2.8 mumol.kg-1.min-1 (6.2 +/- 0.5 mg.kg-1.min-1). Obese normal subjects were also insulin-resistant compared with lean normal subjects, with a GINF of 36.1 +/- 2.2 mumol.kg-1.min-1 (6.5 +/- 0.4 mg.kg-1.min-1), and obesity caused an increase in IR in NIDDM, with a GINF of 21.1 +/- 1.4 mumol.kg-1.min-1 (3.8 +/- 0.25 mg.kg-1.min-1) in the obese NIDDM subjects. Therefore, approximately 61% of the IR in obese NIDDM subjects is due to NIDDM, with 39% due to obesity, demonstrating a greater impact of NIDDM than of obesity in causing IR. The correlation between GINF and BMI was much better in normal subjects (r = -0.75) than in NIDDM subjects (r = -0.50) as was the relationship between fasting insulin level and BMI (r = -0.59 in normal subjects, r = -0.48 in NIDDM subjects). As expected, the fasting insulin level was also strongly correlated to GINF in normal subjects (r = -0.61); however, this relationship was weaker in NIDDM subjects ( r = -0.46). In conclusion, 1) obesity has a major impact to cause insulin resistance in nondiabetic subjects, but the effect of obesity on IR in NIDDM is less; 2) NIDDM per se is the major contributor to IR in NIDDM; and 3) the fasting insulin level is a better surrogate marker of IR in nondiabetic subjects than in NIDDM patients.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Slimani, V. Oikonen, K. Hallsten, N. Savisto, J. Knuuti, P. Nuutila, and P. Iozzo Exercise Restores Skeletal Muscle Glucose Delivery But Not Insulin-Mediated Glucose Transport and Phosphorylation in Obese Subjects J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3394 - 3403. [Abstract] [Full Text] [PDF]

				M. Rewers, D. Zaccaro, R. D'Agostino, S. Haffner, M. F. Saad, J. V. Selby, R. Bergman, and P. Savage Insulin Sensitivity, Insulinemia, and Coronary Artery Disease: The Insulin Resistance Atherosclerosis Study Diabetes Care, March 1, 2004; 27(3): 781 - 787. [Abstract] [Full Text] [PDF]

				B. Ludvik, B. Neuffer, and G. Pacini Efficacy of Ipomoea batatas (Caiapo) on Diabetes Control in Type 2 Diabetic Subjects Treated With Diet Diabetes Care, February 1, 2004; 27(2): 436 - 440. [Abstract] [Full Text] [PDF]

				J. A. Hyder Factors in the Increasing Prevalence of Hypertension JAMA, December 10, 2003; 290(22): 2940 - 2940. [Full Text] [PDF]

				A. E. Butler, J. Janson, W. C. Soeller, and P. C. Butler Increased {beta}-Cell Apoptosis Prevents Adaptive Increase in {beta}-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid Diabetes, September 1, 2003; 52(9): 2304 - 2314. [Abstract] [Full Text] [PDF]

				K. V. Williams, A. Bertoldo, P. Kinahan, C. Cobelli, and D. E. Kelley Weight Loss-Induced Plasticity of Glucose Transport and Phosphorylation in the Insulin Resistance of Obesity and Type 2 Diabetes Diabetes, July 1, 2003; 52(7): 1619 - 1626. [Abstract] [Full Text] [PDF]

				P. A. Kern, G. B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin Expression From Human Adipose Tissue: Relation to Obesity, Insulin Resistance, and Tumor Necrosis Factor-{alpha} Expression Diabetes, July 1, 2003; 52(7): 1779 - 1785. [Abstract] [Full Text] [PDF]

				M. Z. Strowski, M. Kohler, H. Y. Chen, M. E. Trumbauer, Z. Li, D. Szalkowski, S. Gopal-Truter, J. K. Fisher, J. M. Schaeffer, A. D. Blake, et al. Somatostatin Receptor Subtype 5 Regulates Insulin Secretion and Glucose Homeostasis Mol. Endocrinol., January 1, 2003; 17(1): 93 - 106. [Abstract] [Full Text] [PDF]

				A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler {beta}-Cell Deficit and Increased {beta}-Cell Apoptosis in Humans With Type 2 Diabetes Diabetes, January 1, 2003; 52(1): 102 - 110. [Abstract] [Full Text] [PDF]

				J. B. Meigs, C. I. M. Panhuysen, R. H. Myers, P. W.F. Wilson, and L. A. Cupples A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study Diabetes, March 1, 2002; 51(3): 833 - 840. [Abstract] [Full Text] [PDF]

				D. E. Kelley, K. V. Williams, J. C. Price, T. M. McKolanis, B. H. Goodpaster, and F. L. Thaete Plasma Fatty Acids, Adiposity, and Variance of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5412 - 5419. [Abstract] [Full Text] [PDF]

				P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E745 - E751. [Abstract] [Full Text] [PDF]

				A. Mari, G. Pacini, E. Murphy, B. Ludvik, and J. J. Nolan A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test Diabetes Care, March 1, 2001; 24(3): 539 - 548. [Abstract] [Full Text]

				P. A. Kern, R. B. Simsolo, and M. Fournier Effect of Weight Loss on Muscle Fiber Type, Fiber Size, Capillarity, and Succinate Dehydrogenase Activity in Humans J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4185 - 4190. [Abstract] [Full Text]

				M. Christopher, F. L. Hew, M. Oakley, C. Rantzau, and F. Alford Defects of Insulin Action and Skeletal Muscle Glucose Metabolism in Growth Hormone-Deficient Adults Persist after 24 Months of Recombinant Human Growth Hormone Therapy J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1668 - 1681. [Abstract] [Full Text]

				M. Desai, C. D. Byrne, K. Meeran, N. D. Martenz, S. R. Bloom, and C. N. Hales Regulation of hepatic enzymes and insulin levels in offspring of rat dams fed a reduced-protein diet Am J Physiol Gastrointest Liver Physiol, October 1, 1997; 273(4): G899 - G904. [Abstract] [Full Text] [PDF]

				A. Kennedy, T. W. Gettys, P. Watson, P. Wallace, E. Ganaway, Q. Pan, and W. T. Garvey The Metabolic Significance of Leptin in Humans: Gender-Based Differences in Relationship to Adiposity, Insulin Sensitivity, and Energy Expenditure J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1293 - 1300. [Abstract] [Full Text] [PDF]